Cargando…

Ketogenic diet reduces Lafora bodies in murine Lafora disease

Detalles Bibliográficos
Autores principales:	Israelian, Lori, Wang, Peixiang, Gabrielian, Shoghig, Zhao, Xiaochu, Minassian, Berge A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713716/ https://www.ncbi.nlm.nih.gov/pubmed/33324758 http://dx.doi.org/10.1212/NXG.0000000000000533

Ejemplares similares

Everolimus does not prevent Lafora body formation in murine Lafora disease
por: Mishra, Navin, et al.
Publicado: (2017)

PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011)

An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice
por: Nitschke, Silvia, et al.
Publicado: (2020)

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease
por: Nitschke, Felix, et al.
Publicado: (2017)

Retinal Phenotyping of a Murine Model of Lafora Disease
por: Vincent, Ajoy, et al.
Publicado: (2023)

Lafora disease in miniature Wirehaired Dachshunds
por: Swain, Lindsay, et al.
Publicado: (2017)

Extraneurological sparing in long‐lived typical Lafora disease
por: Goldsmith, Danielle, et al.
Publicado: (2018)

Canine Lafora Disease: An Unstable Repeat Expansion Disorder
por: von Klopmann, Thilo, et al.
Publicado: (2021)

Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy
por: Mitra, Sharmistha, et al.
Publicado: (2023)

Retinal alterations in patients with Lafora disease
por: Heitkotter, Heather, et al.
Publicado: (2021)

Identification of proteins potentially involved in the formation of Lafora bodies, a hallmark of Lafora disease
por: Schokraie, Elham, et al.
Publicado: (2013)

Late-onset Lafora disease with prominent parkinsonism due to a rare mutation in EPM2A
por: Lynch, David S., et al.
Publicado: (2016)

Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
por: Sullivan, Mitchell A., et al.
Publicado: (2017)

Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom
por: Ahonen, Saija, et al.
Publicado: (2018)

Correction to: Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom
por: Ahonen, Saija, et al.
Publicado: (2021)

Genotypes and phenotypes of patients with Lafora disease living in Germany
por: Brenner, David, et al.
Publicado: (2019)

Vagus nerve stimulation in Lafora body disease()
por: Hajnsek, Sanja, et al.
Publicado: (2013)

Unusual Course of Lafora Disease
por: Zutt, Rodi, et al.
Publicado: (2016)

AAV-Mediated Artificial miRNA Reduces Pathogenic Polyglucosan Bodies and Neuroinflammation in Adult Polyglucosan Body and Lafora Disease Mouse Models
por: Gumusgoz, Emrah, et al.
Publicado: (2022)

Lafora Disease Masquerading as Hepatic Dysfunction
por: Inayat, Faisal, et al.
Publicado: (2018)

Lafora disease: a case report
por: Zeka, Naim, et al.
Publicado: (2022)

Ocular phenotype and electroretinogram abnormalities in Lafora disease and correlation with disease stage
por: Orsini, Alessandro, et al.
Publicado: (2022)

Lafora Disease: A Ubiquitination-Related Pathology
por: García-Gimeno, Maria Adelaida, et al.
Publicado: (2018)

Treatment with metformin in twelve patients with Lafora disease
por: Bisulli, Francesca, et al.
Publicado: (2019)

Lafora Disease: Report of a Rare Entity
por: Al Mufargi, Younis, et al.
Publicado: (2020)

Trehalose Treatment in Zebrafish Model of Lafora Disease
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

Diabetes Mellitus in a Patient With Lafora Disease: Possible Links With Pancreatic β-Cell Dysfunction and Insulin Resistance
por: Nicolescu, Ramona C., et al.
Publicado: (2019)

An empirical pipeline for personalized diagnosis of Lafora disease mutations
por: Brewer, M. Kathryn, et al.
Publicado: (2021)

Glial Contributions to Lafora Disease: A Systematic Review
por: Della Vecchia, Stefania, et al.
Publicado: (2022)

Progressive Myoclonic Epilepsy Due to Lafora Body Disease with a Novel Mutation
por: Israni, Anil V., et al.
Publicado: (2018)

Periodic electroencephalogram discharges in a case of Lafora body disease: An unusual finding
por: Jain, Rajendra Singh, et al.
Publicado: (2016)

Clinicopathologic Dissociation: Robust Lafora Body Accumulation in Malin KO Mice Without Observable Changes in Home-cage Behavior
por: Krishnan, Vaishnav, et al.
Publicado: (2023)

Genetics of Lafora progressive myoclonic epilepsy: current perspectives
por: Kecmanović, Miljana, et al.
Publicado: (2016)

Loss of GABAergic cortical neurons underlies the neuropathology of Lafora disease
por: Ortolano, Saida, et al.
Publicado: (2014)

Seizure control and improvement of neurological dysfunction in Lafora disease with perampanel
por: Dirani, Maya, et al.
Publicado: (2014)

Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease
por: Burgos, Daniel F., et al.
Publicado: (2020)

Malin restoration as proof of concept for gene therapy for Lafora disease
por: Varea, Olga, et al.
Publicado: (2022)

Electro-clinical features and management of the late stage of Lafora disease
por: d'Orsi, Giuseppe, et al.
Publicado: (2022)

A Case of Lafora Disease Diagnosed by Axillary Skin Biopsy
por: Kımıloğlu, Elife, et al.
Publicado: (2021)

A PTG Variant Contributes to a Milder Phenotype in Lafora Disease
por: Guerrero, Rosa, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_73r1f72gvegtc1v6meput3n9mc